GLIMEPIRIDE TABLETS USP — Class II drug recall D-298-2013
Terminated recall by Qualitest Pharmaceuticals, reported 2013-05-01, distributed nationwide. Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiri
| Recall number | D-298-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Qualitest Pharmaceuticals, Huntsville, AL, United States |
| Recall initiated | 2013-04-19 |
| Classified | 2013-04-25 |
| Reported by FDA | 2013-05-01 |
| Terminated | 2014-01-13 |
| Distributed | Nationwide (US) |
| Quantity | 10,373 bottles |
| NDC | 00603-3745-21 |
| Lot numbers | 12/14, C0671212A |
Product
GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.
Reason for recall
Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-298-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.